Motor neuron synapses with muscle fiber via electrical impulse transmission and neurotransmitter release, forming neuromuscular junctions , motor neuron, neuroscience

SOD1-ALS from Gene Discovery to Targeted Therapeutics: A Comprehensive Review

Joshua Newman, Phillipe Corcia, Angela Genge

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder of upper and lower motor neurons that results in progressive motor impairment. ALS is the most common disease of motor neurons with an annual incidence of approximately 1.7–2.5 per 100,000 people. It is a terminal condition with a typical life expectancy of 2–5 years from symptom onset. […]

touchREVIEWS in Neurology. 2025;21(1):Online ahead of journal publication

Movement Disorders Parkinson's Disease

EAN 2016 K Ray Chaudhuri Interview

Published Online: Jun 24th 2016

K Ray Chaudhuri discusses the key topics on movement disorders from this year’s EAN meeting and the future outlook of Parkinson’s disease therapies.

This Content is for
Members Only

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

Movement disorders at EAN 2024: Key highlights and beyond

K Ray Chaudhuri

Explore ground-breaking advancements in the treatment of movement disorders in this insightful interview with Prof. K. Ray Chaudhuri, who shares his key takeaways from the 10th Congress of the European Academy of Neurology meeting in Helsinki. He discusses promising new therapies, personalized care approaches, and significant research on the staging of Parkinson's. Additionally, Prof. Chaudhuri emphasizes the importance of holistic treatment, stepped-care strategies, remote management, and the potential of wearable technology in improving patient outcomes, bringing his wealth of knowledge and insights to touchNEUROLOGY

Related Videos in Parkinson's Disease

Developed by Touch

Angelo Antonini, EAN 2023: Highlights in Parkinson's disease

touchNEUROLOGY editorial board member Prof. Angelo Antonini (Padua University Hospital, Italy) provides an overview of his top three most important updates and hot topics from the annual European Academy of Neurology (EAN), July 1–4, 2023, in the field of Parkinson's disease. He ...

Developed by Touch

Highlights from EAN 2023!

...

Developed by Touch

Veronica Clark, Parkinson's Europe: Presidential Update, and the Parkinson’s Manifesto for Europe

The European Parkinson’s Disease Association (EPDA) recently changed its name to Parkinson's Europe. They are the only European Parkinson's umbrella organisation and have been working with the global Parkinson’s community for nearly 30 years. As a leading voice for ...

Developed by Touch

Suman Kushwaha, MDS 2022: COVID-19 vaccine induced parkinsonism and cognitive dysfunction

Two cases of COVID-19 vaccination associated neurological symptoms were presented, with patients displaying parkinsonism and cognitive dysfunction. In this touchNEUROLOGY interview, we speak with Dr Suman Kushwaha (Institute of Human Behaviour and Allied Sciences (IHBAS), Dilshad Garden, Delhi, India) to ...

Developed by Touch

Suman Kushwaha, MDS 2022: Neurological symptoms and COVID-19 vaccination

Neurological complications, such as peripheral neuropathy, have been associated with COVID-19 vaccination. In this touchNEUROLOGY interview, we speak with Dr Suman Kushwaha (Institute of Human Behavior and Allied Sciences (IHBAS), Dilshad Garden, Delhi, India) to discuss the neurological symptoms that ...

Developed by Touch

Angelo Antonini, EAN 2022: New therapies and optimal treatment approaches for Parkinson's disease

Data emerging from upcoming clinical trials assessing the treatment efficacy in people with clinically established Parkinson’s disease will shed light on optimal treatment approaches. In this interview with touchNEUROLOGY, Prof. Angelo Antonini (IRCCS San Camillo, Venice, and University of ...

Developed by Touch

Angelo Antonini, EAN 2022: Update on disease-modifying treatments in Parkinson’s disease

Slowing down the progression of Parkinson’s disease is key to improving outcomes. In this interview with touchNEUROLOGY, Prof. Angelo Antonini (IRCCS San Camillo, Venice, and University of Padova, Italy) presents the core concept of the Movement Disorders Society Task ...

Developed by Touch

Heinz Reichmann, EAN 2022: Highlights in Parkinson’s disease

In an interview with touchNEUROLOGY, Prof. Heinz Reichmann (University of Dresden Medical School, Germany) gave us his insight into his highlights in Parkinson’s disease, the interventions currently under investigation and how he sees management strategies for Parkinson’s disease ...

Developed by Touch

Ray Chaudhuri, EAN 2022: Update on opicapone for Parkinson’s disease

Opicapone has proved effective for the treatment of end-of-dose motor fluctuations in patients with Parkinson’s disease. Here, Prof. Ray Chaudhuri (King's College Hospital, London, UK) discusses the effect of disabling fluctuations and dyskinesias on patient quality of life, efficacy ...

Developed by Touch

Tiago Outiero, EAN 2022: Biological versus clinical diagnosis of Parkinson’s disease

Early detection of Parkinson’s disease can vastly improve outcomes. Prof. Tiago Outiero (University Medical Center Goettingen, Goettingen, Germany) discussed with touchNEUROLOGY his research combining basic science to use biological markers and clinical signs to diagnose Parkinson’s disease. Questions: ...

Francisco Cardoso: International Parkinson and Movement Disorder Society (MDS) - President update

The International Parkinson and Movement Disorder Society (MDS) is a professional society of clinicians, scientists, and other healthcare professionals, who are interested in Parkinson’s disease, related neurodegenerative and neurodevelopmental disorders, hyperkinetic movement disorders, and abnormalities in muscle tone and ...

Developed by Touch

Angelo Antonini, AD/PD 2022: Key clinical highlights in movement disorders and Parkinson’s disease

Prof. Angelo Antonini (Professor of Neurology, University of Padua, Padua, Italy) discusses the key clinical highlights and hot topics in movement disorders and Parkinson's disease. Questions: What are the key clinical highlights from the past year in the field of ...

Latest articles videos and clinical updates - straight to your inbox

Log into your Touch Account

Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.

Error:

Forgot Password?

Or log in with

By proceeding, you agree to our terms & conditions.

For information about how we
use your data, see our privacy policy.

Register now for FREE Access

Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.

Already have an Account?

Sign up with an Email

Or use a Social Account.

Error:

By clicking sign up you agree to the website
terms & conditions and privacy policy.

This Functionality is for
Members Only

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

Sign Up for Free Access to the
Latest Clinical Updates in Your Specialty!

Learning Activities

Journals

Specialities

SOD1-ALS from Gene Discovery to Targeted Therapeutics: A Comprehensive Review

Learning Activities

Journals

Specialities

SOD1-ALS from Gene Discovery to Targeted Therapeutics: A Comprehensive Review

EAN 2016 K Ray Chaudhuri Interview

This Content is for
Members Only

Movement disorders at EAN 2024: Key highlights and beyond

Angelo Antonini, EAN 2023: Highlights in Parkinson's disease

Highlights from EAN 2023!

Veronica Clark, Parkinson's Europe: Presidential Update, and the Parkinson’s Manifesto for Europe

Suman Kushwaha, MDS 2022: COVID-19 vaccine induced parkinsonism and cognitive dysfunction

Suman Kushwaha, MDS 2022: Neurological symptoms and COVID-19 vaccination

Angelo Antonini, EAN 2022: New therapies and optimal treatment approaches for Parkinson's disease

Angelo Antonini, EAN 2022: Update on disease-modifying treatments in Parkinson’s disease

Heinz Reichmann, EAN 2022: Highlights in Parkinson’s disease

Ray Chaudhuri, EAN 2022: Update on opicapone for Parkinson’s disease

Tiago Outiero, EAN 2022: Biological versus clinical diagnosis of Parkinson’s disease

Francisco Cardoso: International Parkinson and Movement Disorder Society (MDS) - President update

Angelo Antonini, AD/PD 2022: Key clinical highlights in movement disorders and Parkinson’s disease

Latest articles videos and clinical updates - straight to your inbox

Connect With Us

Useful Links

In Partnership With

Specialities

Sign Up for Free Access to the Latest Clinical Updates in Your Specialty!

Learning Activities

Journals

Specialities

Trending Topic

Connect With Us:

EAN 2016 K Ray Chaudhuri Interview

This Content is forMembers Only

Latest articles videos and clinical updates - straight to your inbox

Log into your Touch Account

Register now for FREE Access

Sign up with an Email

This Functionality is forMembers Only

Sign Up for Free Access to the
Latest Clinical Updates in Your Specialty!

This Content is for
Members Only

This Functionality is for
Members Only